(Q39866191)

15 September 2017

Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo (English)

1 reference

15 September 2017

0 references

1 reference

Alder J

1

1 reference

15 September 2017

Mitten M

2

1 reference

15 September 2017

Jarvis K

3

1 reference

15 September 2017

Gupta P

4

1 reference

15 September 2017

Clement J

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 June 1993

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

37

1 reference

15 September 2017

6

1 reference

15 September 2017

1329-1333

1 reference

Susceptibility of the Lyme disease spirochete to seven antimicrobial agents.

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

Isolation and cultivation of Lyme disease spirochetes

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

Induction of lyme arthritis in LSH hamsters

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

A perspective on the treatment of Lyme borreliosis.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

The early clinical manifestations of Lyme disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

Clinical pathologic correlations of Lyme disease by stage

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

The Spirochetal Etiology of Lyme Disease

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187961

2 December 2018

1 reference

12 December 2020

1 reference

12 December 2020

Ceftriaxone as effective therapy in refractory Lyme disease

1 reference

12 December 2020

In vitro and in vivo susceptibility of Borrelia burgdorferi

1 reference

12 December 2020

Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycin

1 reference

12 December 2020

Treatment of erythema chronicum migrans of Lyme disease

1 reference

12 December 2020

Specific immune responses in Lyme borreliosis. Characterization of T cell and B cell responses to Borrelia burgdorferi

1 reference

12 December 2020

Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi

1 reference

12 December 2020

Serologic tests for Lyme disease. Interlaboratory variability

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.37.6.1329

1 reference

15 September 2017

1 reference

15 September 2017

1 reference